Filing Details

Accession Number:
0001415889-21-004512
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-21 17:53:46
Reporting Period:
2021-09-20
Accepted Time:
2021-09-21 17:53:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1790340 Immuneering Corp IMRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870076 Peter Feinberg 245 Main Street
Second Floor
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-09-20 4,750 $24.45 5,099 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 392,242 Indirect General Partner of PF Associates L.P.
Class A Common Stock 476,615 Indirect General Partner of PEF LLC.
Class A Common Stock 115,441 Indirect General Partner of S4K Investments LLC.
Footnotes
  1. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.75 to $24.75. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.